Pediatric antidepressant use drops 23%
Executive Summary
The number of patients under 18 on antidepressant drugs dropped by 23% in the first two quarters of 2004, Medco reports. The drop in antidepressant use "contrasts sharply to the steady quarterly chartings of the data since 2002," Medco said. The decline in pediatric use of the drugs coincides with FDA health advisories and increased public attention to potential suicidal tendencies associated with the drugs, Medco notes. An FDA analysis of IMS data presented at its Sept. 13-14 meeting on antidepressant suicidality found no decline in new prescriptions for pediatric patients in the first half of 2004...
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.